Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuraxis (NRXS) Operating Expenses (2022 - 2025)

Neuraxis' Operating Expenses history spans 4 years, with the latest figure at $1.9 million for Q3 2025.

  • For Q3 2025, Operating Expenses changed 0.1% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $9.3 million, up 34.14%, while the annual FY2024 figure was $9.2 million, 7.75% up from the prior year.
  • Operating Expenses for Q3 2025 was $1.9 million at Neuraxis, down from $2.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $3.4 million in Q3 2023 and bottomed at $13665.0 in Q2 2022.
  • The 4-year median for Operating Expenses is $1.9 million (2024), against an average of $1.8 million.
  • The largest YoY upside for Operating Expenses was 11732.84% in 2023 against a maximum downside of 97.3% in 2023.
  • A 4-year view of Operating Expenses shows it stood at $1.4 million in 2022, then tumbled by 97.3% to $37231.0 in 2023, then soared by 5990.26% to $2.3 million in 2024, then fell by 16.91% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Operating Expenses are $1.9 million (Q3 2025), $2.2 million (Q2 2025), and $2.9 million (Q1 2025).